Search Results - "Assal, R. A." :: K.UTB vyhledávací portál

Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma

by Shaalan, Yasmin M., Handoussa, H., Youness, R. A., Assal, R. A., El-Khatib, A. H., Linscheid, M. W., El Tayebi, H. M., Abdelaziz, A. I.
Published in Natural product research (17.09.2018)

Get full text

Journal Article

Loading…

Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies

by Rashwan, H.H., Taher, A.M., Hassan, H.A., Awaji, A.A., Kiriacos, C.J., Assal, R.A., Youness, R.A.
Published in Pathology, research and practice (01.04.2024)

Get full text

Journal Article

Loading…

miR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer

by Youness, R.A., Assal, R.A., Abdelmotaal, A., Gad, M.Z.
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

Structural diversity of the cardenolide calotropin renders it as a targeted therapy for harnessing TNBC progression through tuning nitric oxide (NO) levels

by El-Layeh, R A, Youness, R A, Askary, H, Abdelmotaal, A, Assal, R A
Published in Annals of oncology (01.02.2019)

Get full text

Journal Article

Loading…

Regulating rs2278414 (G/A) disease-associated SNP in ZNF350 3’UTR by miR-150-5p: A step towards personalised therapy in breast cancer

by Fouad, E.H., Youness, R.A., Assal, R.A., Gad, M.Z.
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

Mir-506-3p synergistically represses breast cancer progression through altering cell cycle regulators

by Saad El Din, G., Youness, R.A., Assal, R.A., Gad, M.Z.
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

A novel acetylated derivative of vitexin improves the immunogenic profile of breast cancer through tuning miR-20a/MICA Axis

by Awad, A.R., Youness, R.A., Ibrahim, M., Abdelmotaal, A.A., Assal, R.A., Gad, M.Z.
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

Crosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine

by Abdallah, R.M., Youness, R.A., El Meckawy, N., El Sebaaei, A., Abdelmotaal, A.A., Assal, R.A.
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

36PStructural diversity of the cardenolide calotropin renders it as a targeted therapy for harnessing TNBC progression through tuning nitric oxide (NO) levels

by El-Layeh, R A, Youness, R A, Askary, H, Abdelmotaal, A, Assal, R A
Published in Annals of oncology (01.02.2019)

Get full text

Journal Article

Loading…

87PMir-506-3p synergistically represses breast cancer progression through altering cell cycle regulators

by Saad El Din, G, Youness, R A, Assal, R A, Gad, M Z
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

64PRegulating rs2278414 (G/A) disease-associated SNP in ZNF350 3'UTR by miR-150-5p: A step towards personalised therapy in breast cancer

by Fouad, E H, Youness, R A, Assal, R A, Gad, M Z
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

53PmiR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer

by Youness, R A, Assal, R A, Abdelmotaal, A, Gad, M Z
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

50PA novel acetylated derivative of vitexin improves the immunogenic profile of breast cancer through tuning miR-20a/MICA Axis

by Awad, A R, Youness, R A, Ibrahim, M, Abdelmotaal, A A, Assal, R A, Gad, M Z
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

88PCrosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine

by Abdallah, R M, Youness, R A, El Meckawy, N, El Sebaaei, A, Abdelmotaal, A A, Assal, R A
Published in Annals of oncology (01.09.2018)

Get full text

Journal Article

Loading…

Down-regulated miR-486-5p acts as a tumor suppressor in breast cancer patients by targeting the metastatic mediator ICAM-1

by Abdallah, R., Youness, R.A., El Meckawy, N., El Sebaei, A.F., Abdelmotaal, A., Assal, R.A.
Published in Annals of oncology (01.12.2017)

Get full text

Journal Article

Loading…

miR-4317, a novel tumor suppressor miRNA, alleviates immune-suppressive microenvironment induced by breast cancer

by Youness, R.A., Assal, R.A., Hafez, H.M., Abdelmotaal, A., Gad, M.Z.
Published in Annals of oncology (01.12.2017)

Get full text

Journal Article

Loading…

Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

by Assal, RA
Published in Value in health (01.10.2017)

Get full text

Journal Article

Loading…

PCN173 - Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

by Assal, RA
Published in Value in health (01.10.2017)

Get full text

Journal Article

Loading…

PCN166 - Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

by Ragab, MF, Assal, RA, Abdelrahman, MM, Elsisi, G
Published in Value in health (01.11.2016)

Get full text

Journal Article

Loading…

Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

by Ragab, MF, Assal, RA, Abdelrahman, MM, Elsisi, G
Published in Value in health (01.11.2016)

Get full text

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database